Insider Sale: Chief Scientific Officer Dale Muzzey Sells Shares of Myriad Genetics Inc (MYGN)

By Yahoo! Finance | Sep 13, 2024 at 02:06 AM EST

Myriad Genetics Inc focuses on molecular diagnostic testing for disease risk assessment and treatment guidance. Insider transactions reveal selling trend, with recent sale by Dale Muzzey. Stock priced at $26.17, slightly overvalued based on GF Value of $23.47/share.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.